An observational study in Participation Rate, Patient and Clinical Trials, sponsored by Mansoura University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-30.
Sponsored by Mansoura University · Observational
This study aims to investigate the prevalence of refusal of participation in surgical clinical trials in our community. Furthermore, it aims to highlight potential factors contributing to refusal of participation. Finally, it aims to know how to engage patients and their representatives in future surgical clinical trials.
409 studies on the registry are indexed under Patient Participation; 101 are open to participants now.
This study's planned enrollment of 372 is above the median of 170 across 80 observational studies indexed under Patient Participation.
Browse Patient Participation studies →Mansoura University is the lead sponsor of 1,119 studies on the registry; 183 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients admitted to Mansoura University Department 8 at the main hospital, Mansoura University Gastrointestinal Surgery Centre, and Oncology Centre, Mansoura University
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
those patients who would participate in clinical trials
Other: Questionnaire
Questionnaire with questions about accepting participation in clinical research
Prevalence of refusal of participation in surgical clinical trials in our community
Time frame: within 48 hours of admission
potential factors contributing to refusal of participation
Time frame: within 48 hours from admission
Plan to share: No
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.